MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...

Opinion: Lauren Baal weighs up the pros and cons of a bill seeking to make genetic engineering research and technology ...

New research adds to our understanding of the function of the human genome. An international team of researchers has made ...

A new law regulating gene technology in New Zealand is being passed under “Fast Track legislation” and will “bypass” ...

and has revealed the causes of many genetic diseases. But there are inherent limitations to this method. For example, it cannot handle highly repetitive sequences and some kinds of mutations, like ...

Colossal, values the Dallas-based startup at a staggering $10.2 billion. Besides making it the first startup founded in Texas ...

The UK’s plans to adopt the latest gene editing technology face delays over fears they will clash with EU law if Downing Street strikes an agreement with Brussels to remove border checks on food and ...

CRISPR-Cas9 pioneer presented with National Medal of Technology and Innovation in White House awards ceremony.

In this installment, we delve into one of the most debated scientific advancements of our time: CRISPR gene-editing ...

While some mutations in the BRCA2 gene clearly indicate risks for breast and prostate cancer, thousands of less-common ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. UK ministers are pressing ahead with legislation to adopt gene editing technology despite warnings from ...

What is the current share price of Bio-Gene Technology Ltd (BGT)? Bio-Gene Technology Ltd's (BGT) current share price is $0.04. This constitutes a price movement of 2.50% when compared to the share ...